Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Liabilities (2020 - 2022)

Historic Total Liabilities for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $23.4 million.

  • Atea Pharmaceuticals' Total Liabilities fell 9107.47% to $23.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.4 million, marking a year-over-year decrease of 9107.47%. This contributed to the annual value of $62.8 million for FY2021, which is 8011.12% down from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Total Liabilities is $23.4 million, which was down 9107.47% from $33.9 million recorded in Q2 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Total Liabilities peaked at $315.8 million during Q4 2020, and registered a low of $10.9 million during Q3 2020.
  • Over the past 3 years, Atea Pharmaceuticals' median Total Liabilities value was $62.8 million (recorded in 2021), while the average stood at $126.4 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 231033.85% in 2021, then crashed by 9107.47% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Total Liabilities (Quarter) stood at $315.8 million in 2020, then tumbled by 80.11% to $62.8 million in 2021, then tumbled by 62.77% to $23.4 million in 2022.
  • Its last three reported values are $23.4 million in Q3 2022, $33.9 million for Q2 2022, and $37.3 million during Q1 2022.